Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 3
1962 1
1969 1
1983 2
1984 1
1985 2
1987 1
1988 2
1989 1
1990 1
1991 1
1993 1
1994 5
1995 4
1996 5
1997 4
1998 17
1999 3
2000 8
2001 4
2002 5
2003 10
2004 7
2005 9
2006 11
2007 9
2008 4
2009 10
2010 13
2011 12
2012 3
2013 12
2014 12
2015 8
2016 6
2017 8
2018 10
2019 11
2020 14
2021 31
2022 35
2023 32
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

321 results

Results by year

Filters applied: . Clear all
Page 1
Emerging treatment approaches for triple-negative breast cancer.
Capuozzo M, Celotto V, Santorsola M, Fabozzi A, Landi L, Ferrara F, Borzacchiello A, Granata V, Sabbatino F, Savarese G, Cascella M, Perri F, Ottaiano A. Capuozzo M, et al. Among authors: perri f. Med Oncol. 2023 Dec 1;41(1):5. doi: 10.1007/s12032-023-02257-6. Med Oncol. 2023. PMID: 38038783 Review.
p53: From Fundamental Biology to Clinical Applications in Cancer.
Capuozzo M, Santorsola M, Bocchetti M, Perri F, Cascella M, Granata V, Celotto V, Gualillo O, Cossu AM, Nasti G, Caraglia M, Ottaiano A. Capuozzo M, et al. Among authors: perri f. Biology (Basel). 2022 Sep 6;11(9):1325. doi: 10.3390/biology11091325. Biology (Basel). 2022. PMID: 36138802 Free PMC article. Review.
Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors.
Liguori L, Polcaro G, Nigro A, Conti V, Sellitto C, Perri F, Ottaiano A, Cascella M, Zeppa P, Caputo A, Pepe S, Sabbatino F. Liguori L, et al. Among authors: perri f. Pharmaceutics. 2022 Nov 11;14(11):2442. doi: 10.3390/pharmaceutics14112442. Pharmaceutics. 2022. PMID: 36432631 Free PMC article. Review.
Management of recurrent nasopharyngeal carcinoma: current perspectives.
Perri F, Della Vittoria Scarpati G, Caponigro F, Ionna F, Longo F, Buonopane S, Muto P, Di Marzo M, Pisconti S, Solla R. Perri F, et al. Onco Targets Ther. 2019 Feb 26;12:1583-1591. doi: 10.2147/OTT.S188148. eCollection 2019. Onco Targets Ther. 2019. PMID: 30881013 Free PMC article. Review.
Emergencies in oncology: an overview and practical suggestions.
Perri F, Della Vittoria Scarpati G, Pizza C, Carella R, Pontone M, Marciano ML, Longo F, Maglione MG, Buonopane S, Manzo R, Daponte A, Muto P, Ionna F, Cascella M. Perri F, et al. Recenti Prog Med. 2021 Oct;112(10):627-638. doi: 10.1701/3679.36654. Recenti Prog Med. 2021. PMID: 34647532 Review. English.
Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives.
Ottaiano A, Santorsola M, Circelli L, Trotta AM, Izzo F, Perri F, Cascella M, Sabbatino F, Granata V, Correra M, Tarotto L, Stilo S, Fiore F, Martucci N, Rocca A, Picone C, Muto P, Borzillo V, Belli A, Patrone R, Mercadante E, Tatangelo F, Ferrara G, Di Mauro A, Scognamiglio G, Berretta M, Capuozzo M, Lombardi A, Galon J, Gualillo O, Pace U, Delrio P, Savarese G, Scala S, Nasti G, Caraglia M. Ottaiano A, et al. Among authors: perri f. Cancers (Basel). 2023 Mar 17;15(6):1827. doi: 10.3390/cancers15061827. Cancers (Basel). 2023. PMID: 36980713 Free PMC article. Review.
Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives.
Marra A, Ferrone CR, Fusciello C, Scognamiglio G, Ferrone S, Pepe S, Perri F, Sabbatino F. Marra A, et al. Among authors: perri f. Anticancer Agents Med Chem. 2018;18(2):166-181. doi: 10.2174/1871520618666171219115335. Anticancer Agents Med Chem. 2018. PMID: 29256359 Review.
Melanoma Adjuvant Treatment: Current Insight and Clinical Features.
D'Aniello C, Perri F, Scarpati GDV, Pepa CD, Pisconti S, Montesarchio V, Wernert N, Zarone MR, Caraglia M, Facchini G, Berretta M, Cavaliere C. D'Aniello C, et al. Among authors: perri f. Curr Cancer Drug Targets. 2018;18(5):442-456. doi: 10.2174/1568009617666170208163714. Curr Cancer Drug Targets. 2018. PMID: 28183255 Review.
321 results